Raquel F Gerlach

University of São Paulo, San Paulo, São Paulo, Brazil

Are you Raquel F Gerlach?

Claim your profile

Publications (143)413.05 Total impact

  • [Show abstract] [Hide abstract]
    ABSTRACT: To date, no study has employed ozone-based reductive chemiluminescence to compare nitrite concentration in the saliva of periodontal disease (PD) and healthy individuals or in the various blood compartments of the same individuals before and after periodontal treatment. We evaluated nitrite concentrations in whole, submandibular, and parotid saliva, as well as in whole blood, erythrocytes, and plasma of healthy volunteers and patients with chronic periodontitis. Data obtained for the PD and control groups were compared before and 3 months after periodontal therapy. At baseline, stimulated whole saliva nitrite concentration was lower in PD patients (mean = 57.3±9.8 μmol/l) as compared with healthy individuals (92.5±13.6 μmol/l, P<0.05). PD and periodontal treatment did not affect submandibular or parotid saliva nitrite concentrations. PD patients presented higher baseline whole blood nitrite concentration (238.4±45.7 μmol/l) as compared with values recorded 3 months after therapy (141.3±20.1 nmol/l, P<0.05). PD patients' erythrocytes exhibited higher baseline nitrite concentration (573.1±97.8 nmol/l) as compared with three months after therapy (298.7±52.1 nmol/l, P<0.05). Again, PD and PD treatment did not impact plasma nitrite concentration. PD patients had lower nitrite concentration in whole saliva, and this situation remained unchanged after periodontal treatment. Nevertheless, erythrocytes and whole blood nitrite levels diminished after periodontal treatment. Copyright © 2015. Published by Elsevier B.V.
  • Nitric Oxide 11/2014; 42C:124. DOI:10.1016/j.niox.2014.09.077 · 3.18 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Abdominal aortic aneurysm (AAA) is characterized by chronic inflammation and degradation of the extracellular matrix, mediated by matrix metalloproteinases (MMPs). Doxycycline has been reported to control the progression of AAA by regulation of MMP. We hypothesized that doxycycline pretreatment in a rat model of AAA would cause reduction in gelatinolytic activity of MMP-2 and − 9 and the inflammatory response in the wall of an aneurysm, consequently decreasing the formation and development of AAAs.
    Cardiovascular Pathology 11/2014; DOI:10.1016/j.carpath.2014.10.004 · 2.34 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: The present study evaluated the use of a reagent to stabilize the DNA extracted from human dental tissues stored under different temperature conditions and time intervals. Material and Methods: A total of 161 teeth were divided into two distinct groups: intact teeth and isolated dental pulp tissue. The samples were stored with or without the product at different time intervals and temperature. After storage, DNA extraction and genomic DNA quantification were performed using real-time PCR; the fragments of the 32 samples that represented each possible condition were analyzed to find the four pre-selected markers in STR analysis. Results: The results of the quantification showed values ranging from 0.01 to 10,246.88 ng/μL of DNA. The statistical difference in the quantity of DNA was observed when the factors related to the time and temperature of storage were analyzed. In relation to the use of the specific reagent, its use was relevant in the group of intact teeth when they were at room temperature for 30 and 180 days. The analysis of the fragments in the 32 selected samples was possible irrespective of the amount of DNA, confirming that the STR analysis using an automated method yields good results. Conclusions: The use of a specific reagent showed a significant difference in stabilizing DNA in samples of intact human teeth stored at room temperature for 30 and 180 days, while the results showed no justification for using the product under the other conditions tested.
    Journal of applied oral science: revista FOB 07/2014; 22(4):331-335. DOI:10.1590/1678-775720130683 · 0.80 Impact Factor
    This article is viewable in ResearchGate's enriched format
  • [Show abstract] [Hide abstract]
    ABSTRACT: Although disorders of the stomatognathic system are common, the mechanisms involved are unknown. Our objective was to study the changes in the masseter muscles after unilateral exodontia. Molar extraction was performed on Wistar rats (left side), and the animals were sacrificed after either 14 or 26 days. The masseter muscle was processed for histological analysis, conventional and in situ zymography, and immunohistochemistry. The morphological analysis showed unique and specific characteristics for the experimental group. By conventional zymography no significant values of 72 kDa MMP-2 (P < 0.05) were found in both of the sides of masseter muscle after 14 and 26 days of unilateral extraction. The in situ zymography showed gelatinolytic activity on all deep masseter muscles, with significant increase on the contralateral side after 14 and 26 days (P < 0.05). The immunohistochemistry demonstrated greater expression of MMP-2 than MMP-9 and MMP-14 in all masseter muscles and there were few differences in the staining of 4 TIMPs. This knowledge about morphology and molecular masticatory muscle remodeling following environmental interventions can be used to develop clinically successful treatments.
    BioMed Research International 06/2014; 2014:563463. DOI:10.1155/2014/563463 · 2.71 Impact Factor
    This article is viewable in ResearchGate's enriched format
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hypertension induces left ventricular hypertrophy (LVH) by mechanisms involving oxidative stress and imbalanced cardiac matrix metalloproteinase (MMP) activity. We hypothesized that β1-adrenergic receptor blockers with antioxidant properties (nebivolol) could reverse hypertension-induced LVH more effectively than conventional β1-blockers (metoprolol) when used at doses that exert similar antihypertensive effects. Two kidney one clip (2K1C) hypertension was induced in male Wistar rats. Six weeks after surgery, hypertensive and sham rats were treated with nebivolol (10mg.kg(-1).day(-1)) or metoprolol (20mg.kg(-1).day(-1)) for four weeks. Systolic blood pressure (SBP) was monitored weekly by tail-cuff plethysmography. LV structural changes and fibrosis were studied in hematoxylin/eosin and picrosirius stained sections, respectively. Cardiac MMP levels and activity were determined by in situ zymography, gel zymography, and by immunofluorescence. Dihydroethidium (DHE) and lucigenin-derived chemiluminescence assays were used to assess cardiac reactive oxygen species production. Nitrotyrosine levels were determined in LV samples by immunohistochemistry. green fluorescence, and was evaluated using the ImageJ software. Cardiac protein kinase B/Akt (AKT) phosphorilation state was assessed by Western blot. Both treatments exerted very similar antihypertensive effects. Both beta-blockers exerted similar antihypertensive effects and attenuated hypertension-induced cardiac remodeling. Both drugs reduced myocyte hypertrophy and collagen deposition in 2K1C rats. Those effects were associated with lower cardiac ROS and nitrotyrosine levels, and attenuation of hypertension-induced increases in cardiac MMP-2 levels and in situ gelatinolytic activity after treatment with both β-blockers. While hypertension increased AKT phosphorilation, no effects were found with β-blockers. In conclusion, we found evidence that two β1-blockers with different properties attenuate hypertension-induced LV hypertrophy and cardiac collagen deposition in association with significant cardiac antioxidant effects and MMP-2 dowregulation, thus suggesting a critical role for β1-adrenergic receptors in mediating those effects. Nebivolol is not superior to metoprolol, at least with respect to their capacity to reverse hypertension-induced LVH.
    Free Radical Biology and Medicine 06/2014; 73. DOI:10.1016/j.freeradbiomed.2014.05.024 · 5.71 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This MiniReview describes the essential biochemical and molecular aspects of matrix metalloproteinases (MMPs) and briefly discusses how they engage in different diseases, with particular emphasis on cardiovascular diseases. There is compelling scientific evidence that many MMPs, especially MMP-2, play important roles in the development of cardiovascular diseases; inhibition of these enzymes is beneficial to many cardiovascular conditions, sometimes precluding or postponing end-organ damage and fatal outcomes. Conducting comprehensive discussions and further studies on how MMPs participate in cardiovascular diseases is important, because inhibition of these enzymes may be an alternative or an adjuvant for current cardiovascular disease therapy.This article is protected by copyright. All rights reserved.
    Basic & Clinical Pharmacology & Toxicology 06/2014; 115(4). DOI:10.1111/bcpt.12282 · 2.18 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Shed teeth have been proposed as trace element biomarkers. This study determined variations in the spatial distribution of Ca, K, Zn, Pb, Mn, Cu, and Sr in four anatomical locations: superficial enamel (SE, 0-10 μm), subsuperficial enamel (SSE, 10-30 μm), primary dentine (PD), and secondary dentine (SD). Five primary incisors were analyzed by micro Synchrotron Radiation X-Ray Fluorescence (μ-SRXRF). Two teeth had low concentrations of lead in the SE (< 250 μg/g), while three contained very high lead concentrations in the SE (> 2,000 μg/g). Teeth were sliced, and five spot measurements (20 μm beam diameter) were accomplished in each location. The data are shown as absolute values and as the ratio between the different elements and Ca. The distribution of K was close to that of Ca. Zn was the third most abundant element, with the highest levels being found in the SE and SD and low levels detected in the PD. Increasing Sr levels were found progressing from the enamel to the dentine, with the highest levels being found in the SD, a distribution that was unique. Pb, Mn, and Cu exhibited a similar trend, with higher signals for these elements detected in the SE. This study provides preliminary data on the heterogeneous distribution of different elements in the tooth, highlighting the importance of the first 10 μm of the SE for determination of some elements, such as Zn, Pb, Mn, and Cu.
    Journal of Trace Elements in Medicine and Biology 04/2014; DOI:10.1016/j.jtemb.2014.01.007 · 2.49 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to see whether there would be differences in whole blood versus tibia lead concentrations over time in growing rats prenatally. Lead was given in the drinking water at 30 mg/L from the time the dams were pregnant until offspring was 28- or 60-day-old. Concentrations of lead were measured in whole blood and in tibia after 28 (28D) and 60 days (60D) in control (C) and in lead-exposed animals (Pb). Lead measurements were made by GF-AAS. There was no significant difference (P > 0.05) in the concentration of whole blood lead between Pb-28D (8.0 ± 1.1 μ g/dL) and Pb-60D (7.2 ± 0.89 μ g/dL), while both significantly varied (P < 0.01) from controls (0.2 μ g/dL). Bone lead concentrations significantly varied between the Pb-28D (8.02 ± 1.12 μ g/g) and the Pb-60D (43.3 ± 13.26 μ g/g) lead-exposed groups (P < 0.01), while those exposed groups were also significantly higher (P < 0.0001) than the 28D and 60D control groups (Pb < 1 μ g/g). The Pb-60D group showed a 25% decrease in tibia mass as compared to the respective control. The five times higher amount of lead found in the bone of older animals (Pb-60D versus Pb-28D), which reinforces the importance of using bone lead as an exposure biomarker.
    03/2014; 2014:571065. DOI:10.1155/2014/571065
    This article is viewable in ResearchGate's enriched format
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Matrix metalloproteinase‐2 (MMP‐2) shares structural similarities with the angiotensin‐converting enzyme (ACE). ACE inhibitors have been described to inhibit MMP‐2, but this inhibitory potential was not shown using a highly purified MMP‐2. This study aimed to investigate the inhibitory potential of captopril and lisinopril regarding MMP‐2 activity. The first objective was to test the potential of captopril to change the pH of the buffer solution. The second objective was to test the direct inhibitory effect of captopril and lisinopril on plasma MMP‐2 and on recombinant human MMP‐2 (rhMMP‐2). The in vitro activity assays included gelatin zymography and a fluorimetric assay. Captopril solubilization significantly decreased the pH of the 50 mM Tris buffer solution at the following concentrations: 2 mM (p p p p p p p in vivo after drug administration. We also discuss possible pitfalls for gelatinase inhibitory assays (besides the obvious pH problem already cited). In conclusion, this study's data show that captopril and lisinopril did not inhibit MMP‐2 directly at the concentrations reached in vivo.
    Basic &amp Clinical Pharmacology &amp Toxicology 03/2014; 114(3). DOI:10.1111/bcpt.12151 · 2.29 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Activated matrix metalloproteinases (MMPs) cause cardiomyocyte injury during acute pulmonary thromboembolism (APT). However, the functional consequences of this alteration are not known. We examined whether doxycycline (a MMP inhibitor) improves right ventricle function and the cardiac responses to dobutamine during APT. APT was induced with autologous blood clots (350 mg/kg) in anaesthetized male lambs pre-treated with doxycycline (Doxy, 10 mg/kg/day, intravenously) or saline. Non-embolized control lambs received doxycycline pre-treatment or saline. The responses to intravenous dobutamine (Dob, 1, 5, 10 μg/kg/min.) or saline infusions at 30 and 120 min. after APT induction were evaluated by echocardiography. APT increased mean pulmonary artery pressure and pulmonary vascular resistance index by ~185%. Doxycycline partially prevented APT-induced pulmonary hypertension (P < 0.05). RV diameter increased in the APT group (from 10.7 ± 0.8 to 18.3 ± 1.6 mm, P < 0.05), but not in the Doxy+APT group (from 13.3 ± 0.9 to 14.4 ± 1.0 mm, P > 0.05). RV dysfunction on stress echocardiography was observed in embolized lambs (APT+Dob group) but not in embolized animals pre-treated with doxycycline (Doxy+APT+Dob). APT increased MMP-9 activity, oxidative stress and gelatinolytic activity in the RV. Although doxycycline had no effects on RV MMP-9 activity, it prevented the increases in RV oxidative stress and gelatinolytic activity (P < 0.05). APT increased serum cardiac troponin I concentrations (P < 0.05), doxycycline partially prevented this alteration (P < 0.05). We found evidence to support that doxycycline prevents RV dysfunction and improves the cardiac responses to dobutamine during APT.
    Journal of Cellular and Molecular Medicine 11/2013; DOI:10.1111/jcmm.12163 · 3.70 Impact Factor
  • Free Radical Biology and Medicine 11/2013; 65:S80. DOI:10.1016/j.freeradbiomed.2013.10.585 · 5.71 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Increased matrix metalloproteinase (MMP) levels are involved in vascular remodeling of hypertension. In this study, we hypothesized that doxycycline (a MMP inhibitor) could exert antioxidant effects, reverse establish vascular remodeling, and lower blood pressure in spontaneously hypertensive rats (SHR). SHR and Wistar-Kyoto rats received either doxycycline at 30 mg/kg/day by gavage or vehicle. Systolic blood pressure (SBP) was assessed weekly by tail cuff. After 5 weeks of treatment, morphologic changes in the aortic wall were studied in hematoxylin/eosin sections. MMP activity and expression were determined by in situ zymography using DQ gelatin and immunofluorescence for MMP-2. Dihydroethidium was used to evaluate aortic reactive oxygen species (ROS) production by fluorescence microscopy. Doxycycline reduced SBP by 25 mmHg. However, the antihypertensive effects were not associated with significant reversal of hypertension-induced vascular hypertrophy. SHR showed increased aortic MMP-2 levels which co-localized with higher aortic MMP activity and ROS levels, and all those biochemical alterations associated with hypertension were blunted by treatment with doxycycline. These results show that MMP inhibition with doxycycline in SHR with established hypertension resulted in antioxidant effects, lower gelatinolytic activity, and antihypertensive effects which were not associated with reversal of hypertension-induced vascular remodeling.
    Molecular and Cellular Biochemistry 10/2013; 386(1-2). DOI:10.1007/s11010-013-1848-7 · 2.39 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The genetic-molecular methodology stands out as an accurate technique for human identification process and among the sources of biological evidence, the use of teeth is of great interest in Forensic Dentistry. Maintaining integrity of the material sent to laboratory is essential for success of the analysis, and one of the main difficulties is related to sample storage, which is usually carried out at low temperatures. This study evaluated the effectiveness of the Allprotect Tissue Reagent® (Qiagen, Germany) in stabilizing DNA extracted from human dental tissues stored under different conditions. Methods: In this study were used 160 teeth, distributed in two groups: intact teeth and isolated pulp tissue. The samples were stored with or without the product and varying the storage time and temperature. In addition to these groups, was formed a positive control group, composed by five teeth, which was stored at -20ºC for 180 days. After storage, DNA extraction, electrophoresis on agarose gel and genomic DNA quantification by Real-Time PCR were performed. The fragments of 32 samples representing every possible condition and five positive control group samples were analyzed to verify four pre-selected markers. Results: The agarose gel showed evidences of genomic DNA presence. Quantification results showed values ranging from 0.01 to 10,246.88 ng/μL of DNA. There was a decrease in DNA concentration in stored tooth samples at room temperature for 30 and 180 days compared to those stored for 1 and 7 days. Besides the time factor, temperature also influenced the DNA concentration, being higher in teeth that remained for 30 days and in tooth pulp maintained for 180 days, under refrigeration. Regarding the use of Allprotect Tissue Reagent® it showed a significant difference in stabilization of stored teeth at room temperature for 30 and 180 days. The analysis of fragments was possible in 37 selected samples, regardless of the DNA quantity variation, confirming that STR analysis using automated methods provides good results. Conclusion: The use of Allprotect Tissue Reagent® showed a significant difference in stabilizing DNA samples of intact human teeth stored at room temperature for 30 and 180 days, while in the other test conditions the results showed no justification for using this product.
    The Journal of forensic odonto-stomatology 10/2013; 31 Suppl 1:134-5.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Different IL4 haplotypes were associated to susceptibility to/or protection against chronic periodontitis (CP). The aim of this study was to investigate if individuals carrying different haplotypes would present differences in clinical periodontal parameters and in the IL-4 levels at baseline, 45 and 90 days after non-surgical periodontal therapy. Sixty-two patients were subdivided: genetically protected without CP (PH), genetically protected with CP (PCP), genetically susceptible with CP (SCP), genetically susceptible without CP (healthy) (SH). Clinical examination and gingival crevicular fluid (GCF) collection were performed for all patients, and IL-4 levels were measured by ELISA. At baseline, higher values for plaque index (PI, p=0.013), gingival index (GI, p=0.005) were observed for the SCP group in comparison to the PCP group but not after the completion of periodontal therapy. Forty-five and 90 days after the non-surgical therapy, PCP demonstrated significantly higher IL-4 levels than the SCP (p=0.000002). Correlation analysis showed different results between clinical parameters and IL-4 production or GCF volume for groups with different genetic loads. The IL4 gene which was previously associated with susceptibility to CP was related with differences in the IL-4 protein levels in the GCF. However, independent of genetic carriage, individuals responded similarly to this therapy.
    Human immunology 09/2013; 74(12). DOI:10.1016/j.humimm.2013.08.286 · 2.55 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Nebivolol and metoprolol are β1-adrenergic receptor blockers with different properties. We hypothesized that nebivolol, but not metoprolol, could attenuate prooxidant and profibrotic mechanisms of hypertension and therefore protect against the vascular remodeling associated with hypertension. Hypertension was induced in male Wistar rats by clipping the left renal artery. Six weeks after surgery, hypertensive and sham rats were treated with nebivolol (10mg. mg.kg(-1).day(-1)) or metoprolol (20mg.kg(-1).day(-1)) for four weeks. Systolic blood pressure was monitored weekly. Morphologic changes in the aortic wall were studied in hematoxylin/eosin and picrosirius red sections. Aortic NAD(P)H activity and superoxide production were evaluated by luminescence and dihydroethidium, respectively, and TBARS levels were measured in plasma. Aortic nitrotyrosine staining was evaluated to assess peroxynitrite formation. TGF-β levels and p-ERK 1/2 expression were determined by immunofluorescence and western blotting, respectively. Matrix metalloproteinase (MMP) activity and expression were determined by in situ zymography, gel zymography, western blotting and immunofluorescence, and TIMP-1 was assessed by immunohistochemistry. Both β1-receptor antagonists exerted very similar antihypertensive effects. However, while metoprolol had no significant effects, nebivolol significantly attenuated vascular remodeling and collagen deposition associated with hypertension. Moreover, nebivolol, but not metoprolol, attenuated hypertension-induced increases in aortic NAD(P)H oxidase activity, superoxide production, TBARS concentrations, nitrotyrosine levels, TGF-β upregulation and MMP-2 and -9 expression/activity. No effects on p-ERK 1/2 and TIMP-1 expression were found. These results show for the first time that nebivolol, but not metoprolol, attenuates prooxidant and profibrotic mechanisms involving TGF-β and MMP-2 and MMP-9, which promote vascular remodeling in hypertension.
    Free Radical Biology and Medicine 06/2013; 65. DOI:10.1016/j.freeradbiomed.2013.06.033 · 5.27 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Reduced nitric oxide (NO) bioavailability and imbalanced matrix metalloproteinase (MMP) activity have important roles in the pathogenesis of cardiovascular diseases, and some NO donors were shown to downregulate MMP expression in some cell types. However, while nitrite and nitrate can be recycled back to NO by non enzymatic and enzymatic mechanisms as an alternative to NO formation from l-arginine, no previous study has examined whether sodium nitrite can downregulate stimulated MMP release by endothelial cells. Objective We examined the effect of sodium nitrite and sodium nitrate on MMP-9 production by endothelial cells. Methods Human umbilical vein endothelial cells were cultured in a modified DMEM (iron(III) nitrate is replaced by iron(III) sulfate) and treated for 24 h with 10 nM phorbol myristate acetate (PMA; a MMP-9 inducer) and sodium nitrite or sodium nitrate, or their vehicles. Conditioned medium were analyzed by gelatin zimography to assess MMP-9 activity. Results PMA increased MMP-9 activity from 0.02 ± 0.01 arbitrary units (AU) to 1.14 ± 0.34 AU (P < 0.05). While low nitrite concentrations (0.2 or 2 μM) attenuated the increases in MMP-9 activity induced by PMA (0.77 ± 0.12 AU or 0.71 ± 0.14 AU, respectively; both P < 0.05 vs. PMA), high nitrite concentrations (10 or 20 μM) had no effects on PMA-induced increases in MMP-9 activity (0.88 ± 0.14 AU or 1.18 ± 0.36 AU, respectively; both P > 0.05 vs. PMA). Both low (10 or 100 μM) or high (200 or 400 μM) nitrate concentrations had no effects on PMA-induced increases in MMP-9 activity PMA (P > 0.05 vs. PMA). Conclusion Our results suggest that low nitrite (but not nitrate) concentrations attenuate MMP-9 production by endothelial cells. Financial support FAPESP, CNPq, FAEPA. Disclosure Nothing to disclose.
    Nitric Oxide 04/2013; 31:S33. DOI:10.1016/j.niox.2013.02.048 · 3.18 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Decreased nitric oxide (NO) bioavailability and up-regulated MMP activity contribute to hypertension-induced cardiovascular hypertrophy. However, it is uncertain whether NO affects MMP activity. Dietary nitrite is an alternative source of NO and may exert antioxidant effects, thus affecting up-regulated MMP hypertension. We evaluated whether sodium nitrite treatment reduces cardiac MMP in 2-kidney, 1-clip (2K1C) hypertension. Sham and 2K1C rats were treated with vehicle or sodium nitrite (15 mg/kg orally) for 4 weeks. Systolic blood pressure was monitored weekly. Plasma nitrite concentrations were analyzed by chemiluminescence. Cardiac MMP level/activity were determined by gelatin and in situ zymography. Sodium nitrite treatment exerted antihypertensive effects in 2K1C rats (P < 0.05). We found lower plasma nitrite concentrations in 2K1C rats when compared with the Sham group (P < 0.05), and nitrite treatment restored these levels in 2K1C rats. 2K1C hypertension increased cardiac MMP-2 levels and MMP activity (P < 0.05). Sodium nitrite treatment reduced hypertension-induced increases in both MMP levels and activity (P < 0.05). Our results suggest that sodium nitrite treatment prevents 2K1C hypertension-induced MMP up-regulation, and therefore may prevent cardiac remodeling associated with hypertension. Supported by: FAPESP, CNPq. Disclosure Nothing to disclose.
    Nitric Oxide 04/2013; 31:S32. DOI:10.1016/j.niox.2013.02.046 · 3.18 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases with an important role in physiological and pathological remodeling. Their activity is regulated by tissue inhibitors of matrix metalloproteinases (TIMPs). Excess MMPs and myeloperoxidase (MPO) activity has been associated with loss of tooth supporting tissues in periodontal disease (PD). We investigate the changes in salivary MMP-8, MMP-9, TIMP-1, TIMP-2, and MPO concentrations during PD treatment and compare results with plasma levels. METHODS: MMP-8, MMP-9, TIMP-1 and TIMP-2 were analyzed by ELISA. Gelatinolytic activity of MMP-9 forms were determined by zymography, and the MPO activity was determined by colorimetric assay. RESULTS: Subjects were divided into 2 groups: PD and control, which were further divided into 2 subgroups each, namely PD before (PB) and after 3months (PA) of non-surgical periodontal therapy, and healthy volunteers at baseline (CB) and 3months after baseline (CA). Subgroup PA presented lower gelatinolytic activity and MMP-8 and TIMP-2 concentrations in the saliva compared with PB (p<0.05). MPO activity was higher in PB compared with CB (p<0.05). There were significant correlations between the gelatinolytic activity of the saliva and MMP-8 and MMP-9 plasma levels. There was significant correlation between plasma and saliva TIMP-2 levels. CONCLUSION: These results suggest attenuation of some inflammatory markers in the saliva and plasma after PD treatment. Moreover, correlations between salivary and plasma levels exist for some of these markers.
    Clinica chimica acta; international journal of clinical chemistry 03/2013; 421. DOI:10.1016/j.cca.2013.03.008 · 2.54 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Cardiovascular diseases involve critical mechanisms including impaired nitric oxide (NO) levels and abnormal matrix metalloproteinase (MMP) activity. While NO downregulates MMP expression in some cell types, no previous study has examined whether NO downregulates MMP levels in endothelial cells. We hypothesized that NO donors could attenuate MMP-9 production by human umbilical vein endothelial cells (HUVECs) as a result of less NFκB activation or cyclic GMP (cGMP)-mediated mechanisms. We studied the effects of DetaNONOate (10-400 μM) or SNAP (50-400 μM) on phorbol 12-myristate 13-acetate (PMA; 10 nM)-induced increases in MMP-9 activity (by gel zymography) or concentrations (by ELISA) as well as on a tissue inhibitor of MMPs' (TIMP)-1 concentrations (by ELISA) in the conditioned medium of HUVECs incubated for 24 h with these drugs. We also examined whether the irreversible inhibitor of soluble guanylyl cyclase ODQ modified the effects of SNAP or whether 8-bromo-cGMP (a cell-permeable analog of cGMP) influenced PMA-induced effects on MMP-9 expression. Total and phospho-NFκB p65 concentrations were measured in HUVEC lysates to assess NFκB activation. Both NO donors attenuated PMA-induced increases in MMP-9 activity and concentrations without significantly affecting TIMP-1 concentrations. This effect was not modified by ODQ, and 8-bromo-cGMP did not affect MMP-9 concentrations. While PMA increased phospho-NFκB p65 concentrations, SNAP had no influence on this effect. In conclusion, this study shows that NO donors may attenuate imbalanced MMP expression and activity in endothelial cells independent of cGMP- or NFκB-mediated mechanisms. Our results may offer an important pharmacological strategy to approach cardiovascular diseases.
    Molecular and Cellular Biochemistry 03/2013; 378(1-2). DOI:10.1007/s11010-013-1602-1 · 2.39 Impact Factor

Publication Stats

3k Citations
413.05 Total Impact Points

Institutions

  • 2005–2015
    • University of São Paulo
      • • Ribeirão Preto School of Dentistry (FORP)
      • • Ribeirão Preto School of Medicine (FMRP)
      San Paulo, São Paulo, Brazil
  • 2000–2012
    • University of Campinas
      • • Faculdade de Ciências Médicas (FCM)
      • • Faculty of Dentistry from Piracicaba
      Campinas, Estado de Sao Paulo, Brazil
  • 2011
    • University of Alberta
      • Department of Pharmacology
      Edmonton, Alberta, Canada
  • 2004–2011
    • Universidade de Ribeirão Preto
      Entre Rios, São Paulo, Brazil
  • 2006
    • Humboldt-Universität zu Berlin
      Berlín, Berlin, Germany